Laurus Labs Q1 net surges to ₹163 cr on higher revenue
Generic drugmaker and biotech company Laurus Labs reported consolidated net profit for June quarter surged to ₹163 crore from ₹13 crore year earlier. The higher net profit came on a 31% increase in revenue from operations to ₹1,570 crore (₹1,195 crore). Founder and CEO Satyanarayana Chava attributed the performance to increasing contributions from CDMO business…
Read More “Laurus Labs Q1 net surges to ₹163 cr on higher revenue” »